Drug Channel Updates
Timely updates on drug shortages, launches, recalls, and more.
Top shortages
Amoxicillin Pt400mg/5ml 75ml increased demand is causing this shortage.
Morphine Various Strengths and Sizes Morphine continues to be in short supply. Limited supplies come in, but don’t last long.
Naltrexone Hcl Tab 50mg 30s Increased demand is causing this shortage.
Rezatriptan Benzo Tab 10mg 4x3uu Capacity constraints are causing this shortage.
Drug Launches
The latest insights on the drug market.
Recent Launches
Complera (emtricitabine, rilpivirine, hydrochloride and tenofovir disproval funarate) launched at the end of May. This is a $107-million market and Mylan will be our source vendor.
Fycompa (perampanel) launched June 2. This is a $244 million market. Teva will be our source vendor. r
Jynarque (Tolvaptan) launched May 30. This is a $1.1 billion market and is a highly specialized item in a closed market. Apotex will be our source vendor.
Tasigna (Nilotinib Hydrochloride) launched May 23, with name-brand sales of $1.2 billion. Apotex will be our source vendor. This is a specialty item and is very expensive.
Upcoming Launches
Arnuity Ellipta (fluticasone furoate) is a $334 million market and is anticipated to launch in late August. Prasco will be the source vendor.
Ernesto (sacubitril; valsartan) is a $5.4 billion market and is expected to launch in mid to late July.
Ravicti (glycerol phenyibutyrate) is a $469 million market and is anticipated to launch in early July.
Rytary (carbidopa; levodopa) is a $337 million market. It is expected to launch in late July. Sandostatin LAR 20mg (octreotide acetate) is a $664 million market scheduled to launch around mid-July, though 10mg and 30mg are already available.
Saxenda (liraglutide recombinant) is a $217 million market and is now anticipated to launch sometime in September. Teva has been authorized to supply but is having operational delays.
Day 181
Mesnex (mesna) is a $6 million market. Available in July. The current source vendor is Ingenus.
Namzaric 14mg-10mg & 28mg-10mg (donepezil/memantine) is a $70 million market and will be available to others in July. The current source vendor is Amneal.
Recalls
The most recent recall information with return forms.
AMNEAL
Company Name: Amneal Pharmaceutical LLC
Product Description: Sulfamethoxazole/Trimethoprim Tablets, USP, 400mg/80mg
Recall Reason: Microbial contamination
Zicam® and Orajel™
Company Name: Church & Dwight Co., Inc.
Product Description: Cold Remedy Nasal Swabs, Nasal AllClear Swabs, Baby Teething Swabs
Recall Reason: Microbial contamination